NCT01149837View on ClinicalTrials.gov

Evaluation of InnoLIA HTLV I/II Score

CompletedOBSERVATIONAL
Enrollment

3,305

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 25, 2019

Study Completion Date

January 25, 2019

Conditions
Human T-Lymphotrophic Virus Type I and/or Type II
Interventions
DEVICE

InnoLIA HTLV I/II Score line immunoassay

This intervention consists of testing a residual serum or plasma sample from a blood donation or donor follow-up sample using the InnoLIA HTLV I/II Score line immunoassay

Trial Locations (1)

85282

Creative Testing Solutions, Tempe

Sponsors
All Listed Sponsors
lead

Creative Testing Solutions

OTHER